BSAC is the National Science Foundation Industry/University Cooperative Research Center for Microsensors and Microactuators, conducting industry-relevant, interdisciplinary research on micro- and nano-scale sensors, moving mechanical elements, microfluidics, materials, and processes that take advantage of progress made in integrated-circuit, bio, and polymer technologies.
UNAM-Institute of Materials Science and Nanotechnology has emerged from a project of Bilkent University aiming at establishing a national nanotechnology research center in Turkey. Research facilities are expanding rapidly in order to host 100 professional researchers with Ph.D. degrees and at least 300 graduate students. UNAM is growing as a center of excellence in nanotechnology and is operating as a high level national research facility that serves to all interested researchers and users from universities, state enterprises and private sector all over Turkey.
The Materials Science and Nanotechnology graduate program has started accepting applications. Students from departments of materials science, physics, electronics, chemistry, mechanical engineering, biotechnology, genetics, pharmacy, mechatronics, agriculture and textile can apply.
The vision of BIODOT is a hybrid bio-organic technology for transduction of dynamical phenomena of biosystems in-vitro. The device that will be developed is based on organic ultra thin film transistors integrated with microfluidics.
The Biologically Inspired Materials Institute (BIMat) was established by NASA under the University Research, Engineering and Technology Institute (URETI) program. The principal goal for BIMat researchers is to develop bio-nanotechnology materials and structures for aerospace vehicles.
This EU project seeks to provide Europe with a major time advantage over their main international competitors by developing a bionanotechnological device that can be used as a nanoactuator/biosensor, which also provides a novel interface between the Biological and Silicon Worlds.
BioNanoNet is a bionanotechnology network in Austria that carries out innovative interdisciplinary research in the field of drug development. Within this network new agents, action and application strategies are being developed by using techniques of nanotechnology. Research efforts are aimed at finding new agents and new treatment strategies for chronic degenerative and infectious diseases.
The BIOTEX project aims at developing dedicated biochemical-sensing techniques compatible with integration into textile. The consortium includes two research institutes in the field of micro and nanotechnology.
Boeing Phantom Works is the advanced research and development unit at Boeing and the catalyst of innovation for the Boeing enterprise. For instance, they are working to create an entirely new class of nanostructured aluminum alloys. These lab-produced materials deliver titanium's strength - over a wide temperature range - in a much lighter material.
The mission of the group is to provide a rewarding and nourishing atmosphere of hands-on cutting edge research for students to develop and grow professionally and technically and use as an opportunity to springboard to a professional career that will benefit them and society.
The department has a strong record of research, with faculty involved in both experimental and theoretical areas. Some areas of current interest are: novel electronic materials; carbon nanotubes and nanotube arrays; theory of marginal Fermi liquids; optical and transport properties of low- dimensional condensed matter systems; novel superconductors.
Research in Optical Characterization and Nanophotonics (OCN) laboratory focuses on developing and applying advanced optical characterization techniques to the study of solid-state and biological phenomena at the nanoscale.
Highly interdisciplinary and translational, the group's research is focused on multifunctional, nanoparticle-based drug delivery systems. They seek to improve nanoparticle synthesis and formulation and its therapeutic efficacy. Additionally, they develop robust engineering processes to accelerate translation of nanoparticle-based drugs into the drug development pipeline. At the same time, they emphasize a fundamental understanding of the interface between nanomaterials and biological systems.
With the global benefits of the new science of nanomedicine growing each year, the British Society for Nanomedicine has been created to allow open access for industry, academia, clinicians and the public to news and details of ongoing research throughout the UK.